Search Results - "Poey, Nora"
-
1
Is Cutibacterium acnes early surgical site infection rate related to the duration of antibiotic prophylaxis in adolescent idiopathic scoliosis surgery?
Published in European spine journal (01-07-2020)“…Purpose Cutibacterium acnes ( C. acnes) is a gram-positive anaerobic bacillus located in pilosebaceous glands, usually responsible for late postoperative…”
Get full text
Journal Article -
2
Correction to: Is Cutibacterium acnes early surgical site infection rate related to the duration of antibiotic prophylaxis in adolescent idiopathic scoliosis surgery?
Published in European spine journal (01-08-2020)“…Unfortunately, the authors first name and family name were incorrectly swapped in the original publication. The complete correct names of the author group is…”
Get full text
Journal Article -
3
Sociodemographic characteristics and transmission risk factors in patients hospitalized for COVID-19 before and during the lockdown in France
Published in BMC infectious diseases (13-08-2021)“…Abstract Background The efficacy of lockdown in containing the COVID-19 pandemic has been reported in different studies. However, the impact on…”
Get full text
Journal Article -
4
Impact of Deprivation on the Incidence and Severity of Tuberculosis in Children: A Retrospective Study from 2007 to 2020 in a Tertiary Care Center in Paris, France
Published in The Journal of pediatrics (01-08-2023)“…To assess the association between deprivation and the incidence and clinical severity of tuberculosis (TB) in children. Children ≤18 years old who were…”
Get full text
Journal Article -
5
Evaluation of the RealStar® SARS-CoV-2 RT-PCR kit RUO performances and limit of detection
Published in Journal of clinical virology (01-08-2020)“…•The RealStar® SARS-CoV-2 RT-PCR Kit RUO (Altona) provides a SARS-CoV-2 assay compatible with various real-time PCR platforms.•It present a strong pourcentage…”
Get full text
Journal Article -
6
Tularemia in Pediatric Patients: A Case Series and Review of the Literature
Published in The Pediatric infectious disease journal (23-09-2024)“…Unfamiliar to pediatricians, tularemia can lead to delays in diagnosis and hinder appropriate treatment, as its clinical presentation often shares similarities…”
Get full text
Journal Article -
7
Diagnostic Accuracy of Blind Bronchial Sample Testing by BioFire Pneumonia plus Panel in Pediatric Intensive Care Unit Patients and Its Impact in Early Adaptation of Antimicrobial Therapy: A Prospective Observational Study
Published in The Pediatric infectious disease journal (01-08-2024)“…Community-acquired and nosocomial lower-respiratory-tract infections in critically ill pediatric patients require early appropriate antibiotic therapy to…”
Get full text
Journal Article -
8
-
9
Aminoglycosides Monotherapy as First-Line Treatment for Febrile Urinary Tract Infection in Children
Published in The Pediatric infectious disease journal (01-11-2017)“…We report a retrospective monocentric descriptive study performed in CHI Creteil for 20 months to describe the management and outcome of amikacin monotherapy…”
Get full text
Journal Article -
10
Retrospective Multicentric Study on Campylobacter spp. Bacteremia in France: The Campylobacteremia Study
Published in Clinical infectious diseases (10-09-2022)“…Campylobacter spp. bacteremia is a severe infection. A nationwide 5-year retrospective study was conducted to characterize its clinical features and prognostic…”
Get full text
Journal Article -
11
Multicenter Retrospective Study of Vascular Infections and Endocarditis Caused by Campylobacter spp., France
Published in Emerging infectious diseases (01-03-2023)“…The incidence of campylobacteriosis has substantially increased over the past decade, notably in France. Secondary localizations complicating invasive…”
Get full text
Journal Article -
12
The expanded French compassionate programme for elexacaftor–tezacaftor–ivacaftor use in people with cystic fibrosis without a F508del CFTR variant: a real-world study
Published in The lancet respiratory medicine (01-11-2024)“…Elexacaftor–tezacaftor–ivacaftor has been approved in Europe for people with cystic fibrosis with at least one F508del CFTR variant. Additionally, it is…”
Get full text
Journal Article -
13
The expanded French compassionate programme for elexacaftor–tezacaftor–ivacaftor use in people with cystic fibrosis without a F508del CFTR variant: a real-world study
Published in The lancet respiratory medicine (01-08-2024)“…Background Elexacaftor-tezacaftor-ivacaftor has been approved in Europe for people with cystic fibrosis with at least one F508del CFTR variant. Additionally,…”
Get full text
Journal Article -
14
-
15